Form 4: Heart Test Laboratories Director Acquires Shares from Family Trust

Andrew Simpson, a director at Heart Test Laboratories, acquired 17 shares of common stock from the Simpson Family Benefit Trust on August 12, 2024.

Summary

• On August 12, 2024, Andrew Simpson, a director, officer, and Chairman of the Board, President and Chief Executive Officer at Heart Test Laboratories, Inc. (HSCS), acquired 17 shares of common stock.
• The shares were transferred from the Simpson Family Benefit Trust, of which Mr. Simpson was a beneficiary but did not have voting or dispositive power.
• Following the transaction, Mr. Simpson directly owns 7,629 shares of Heart Test Laboratories, Inc.
• The share amount takes into account a 1-for-100 reverse stock split effective May 17, 2024.

Sentiment

Score: 5

Explanation: The document is a neutral regulatory filing, so the sentiment is neither positive nor negative.

Industry Context

This filing is a routine disclosure of insider trading activity, which is common for publicly traded companies. It provides transparency into the transactions of company insiders.

Stakeholder Impact

• The transaction has a minimal impact on stakeholders as it involves a small number of shares being transferred.

Key Dates

Keywords

Heart Test Laboratories, HSCS, Andrew Simpson, stock acquisition, Form 4, beneficial ownership, reverse stock split, Simpson Family Benefit Trust